Dr. Rachel Loeber is a medicinal chemist by training with extensive experience in analytical chemistry, organic chemistry, and pharmacology. She earned her B.S. from the University of Wisconsin – River Falls with a dual major in Biochemistry and Biotechnology followed by a Ph.D. in Medicinal Chemistry in the laboratory of Dr. Natalia Tretyakova at the University of Minnesota’s Masonic Cancer Center. Her research focused on gaining a better understanding of the chemical mechanisms of carcinogenesis and the therapeutic actions of anti-tumor drugs.
At LeafLine Labs, Dr. Loeber oversees both production and R&D activities involving cannabis extraction, medical cannabis formulation, analytical testing, and regulatory compliance. She has drawn from her previous industrial laboratory experience to bring scientific rigor and good laboratory practices to LeafLine Labs, differentiating them as a leader in the ever-evolving medical cannabis industry.
Dr. Loeber enjoys networking with other scientists and is an active member of numerous scientific and cannabis-specific interest groups.